Reynolds TM

ORCID: 0000-0002-9729-4775 · 2 papers in corpus
2013
BMC women's health ·doi:10.1186/1472-6874-13-8

BackgroundNICE guidance on the investigation and treatment of ovarian cancer advocates that the tumour marker CA125 should be the first line investigation for women suspected of having ovarian cancer.MethodsAn internet-based survey, of prim…

2005
Journal of clinical pathology ·doi:10.1136/jcp.2004.018077

BackgroundCA125 is a high molecular weight glycoprotein, which is expressed by a large proportion of epithelial ovarian cancers. The sensitivity and specificity of CA125 are poor and there are no guidelines produced by the Royal College of …